Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Pasello

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|July 26, 2023
Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in <i>RET</i> fusion-positive non-small cell lung cancer: a case reportDaniela Scattolin, Elena Scagliori, Antonio Scapinello, et al.
British Journal of Cancer|December 11, 2019
Metabolic rewiring and redox alterations in malignant pleural mesotheliomaLoredana Urso, Ilaria Cavallari, Evgeniya Sharova, et al.
Future Oncology (London, England)|January 14, 2026
Lorlatinib atypical safety profile in ALK-positive aNSCLC: tips for management from an Italian expert panelAndrea Ardizzoni, Diego Cortinovis, Bruno Gori, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Oncotarget|March 3, 2016
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationValentina Polo, Giulia Pasello, Stefano Frega, et al.
Histopathology|June 6, 2020
Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfallFederica Pezzuto, Francesco Fortarezza, Marco Mammana, et al.
Critical Reviews in Oncology/Hematology|June 10, 2019
Corrigendum to "Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?" [Crit. Rev. Oncol. Hematol. 138 (June) (2019), 87-103]Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Nuclear Medicine Communications|May 3, 2019
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapyLaura Evangelista, Lea Cuppari, Jessica Menis, et al.
International Journal of Molecular Sciences|April 19, 2019
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung CancerLaura Bonanno, Elisabetta Zulato, Alberto Pavan, et al.
Cancers|May 28, 2020
Novel Nuclear Medicine Imaging Applications in Immuno-OncologyStefano Frega, Alessandro Dal Maso, Giulia Pasello, et al.
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|July 26, 2023
Small bowel edema and lymphocytic duodenitis as severe reversible gastrointestinal toxicity of selpercatinib in <i>RET</i> fusion-positive non-small cell lung cancer: a case reportDaniela Scattolin, Elena Scagliori, Antonio Scapinello, et al.
British Journal of Cancer|December 11, 2019
Metabolic rewiring and redox alterations in malignant pleural mesotheliomaLoredana Urso, Ilaria Cavallari, Evgeniya Sharova, et al.
Future Oncology (London, England)|January 14, 2026
Lorlatinib atypical safety profile in ALK-positive aNSCLC: tips for management from an Italian expert panelAndrea Ardizzoni, Diego Cortinovis, Bruno Gori, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Oncotarget|March 3, 2016
Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterizationValentina Polo, Giulia Pasello, Stefano Frega, et al.
Histopathology|June 6, 2020
Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfallFederica Pezzuto, Francesco Fortarezza, Marco Mammana, et al.
Critical Reviews in Oncology/Hematology|June 10, 2019
Corrigendum to "Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?" [Crit. Rev. Oncol. Hematol. 138 (June) (2019), 87-103]Stefano Frega, Alessandro Dal Maso, Alessandra Ferro, et al.
Nuclear Medicine Communications|May 3, 2019
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapyLaura Evangelista, Lea Cuppari, Jessica Menis, et al.
International Journal of Molecular Sciences|April 19, 2019
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung CancerLaura Bonanno, Elisabetta Zulato, Alberto Pavan, et al.
Cancers|May 28, 2020
Novel Nuclear Medicine Imaging Applications in Immuno-OncologyStefano Frega, Alessandro Dal Maso, Giulia Pasello, et al.
Pageof 17